|
2006 Conference Publication Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban QueenslandCoulson, F. R. and Tett, S. E. (2006). Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban Queensland. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, 7-9 June 2006. Brisbane: National Prescribing Service. |
|
2006 Conference Publication Tinkering with the immune system - When, why and how for optimal therapeuticsTett, S. E. (2006). Tinkering with the immune system - When, why and how for optimal therapeutics. Canadian Therapeutics Congress, Toronto, Canada, May 2006. Canada: Canadian Association of Population therapeutics; Canadian Society for Clinical Pharmacology. |
|
2006 Journal Article Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004Chan, V. and Tett, S. E. (2006). Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period 1992-2004. Pharmacoepidemiology And Drug Safety, 15 (7), 462-468. doi: 10.1002/pds.1256 |
|
2006 Journal Article How is leflunomide prescribed and used in Australia? analysis of prescribing and adverse effect reportingChan, V. and Tett, S. E. (2006). How is leflunomide prescribed and used in Australia? analysis of prescribing and adverse effect reporting. Pharmacoepidemiology And Drug Safety, 15 (7), 485-493. doi: 10.1002/pds.1252 |
|
2006 Conference Publication Non-steroidal anti-inflammatory drug prescription in relation to the prescribing of gastroprotective drugs in AustraliaBarozzi, N. and Tett, S. E. (2006). Non-steroidal anti-inflammatory drug prescription in relation to the prescribing of gastroprotective drugs in Australia. 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, 24-27 August 2006. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/pds.1295 |
|
2006 Conference Publication Revamped, redeveloped, relaunched...the new QUMmapTett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2006). Revamped, redeveloped, relaunched...the new QUMmap. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, Australia, 7-9 June, 2006. Brisbane, Qld, Australia: National Prescribing Service. |
|
2005 Journal Article Consumer involvement in quality use of medicines (QUM) projects - lessons from AustraliaKirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75 |
|
2005 Journal Article Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationStaatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4 |
|
2005 Journal Article Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, AustraliaCooke, C., Nissen, L. M., Sketris, I. S. and Tett, S. E. (2005). Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clinical Therapeutics, 27 (4), 497-508. doi: 10.1016/j.clinthera.2005.04.009 |
|
2005 Journal Article Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritisChan, V., Charles, B. G. and Tett, S. E. (2005). Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. British Journal of Clinical Pharmacology, 60 (3), 257-264. doi: 10.1111/j.1365-2125.2005.02415.x |
|
2005 Conference Publication Directions for pharmacy as we move forwardTett, S. E. (2005). Directions for pharmacy as we move forward. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Empiric management of community-acquired pneumonia in Australian emergency departmentsMaxwell, D. J., McIntosh, K. A., Pulver, L. K., Easton, K. L., CAPTION Study Grp and Tett, S. E. (2005). Empiric management of community-acquired pneumonia in Australian emergency departments. Medical Journal of Australia, 183 (10), 520-524. doi: 10.5694/j.1326-5377.2005.tb07153.x |
|
2005 Other Outputs Rural community pharmacists integrating care for people with complex health needsNissen, L. M. and Tett, S. E. (2005). Rural community pharmacists integrating care for people with complex health needs. Brisbane: Pharmacy Guild of Australia. |
|
2005 Conference Publication Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamolBarozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Journal Article Mycophenolic acid pharmacokinetics and related outcomes early after renal transplantAtcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x |
|
2005 Conference Publication Influences on the prescribing of new drugs in rural and urban Queensland: The example of COX-2 inhibitorsBehan, K., Cutts, C. and Tett, S. E. (2005). Influences on the prescribing of new drugs in rural and urban Queensland: The example of COX-2 inhibitors. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsBehan, K., Cutts, C. and Tett, S. E. (2005). Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors. Journal of Clinical Pharmacy And Therapeutics, 30 (4), 337-343. doi: 10.1111/j.1365-2710.2005.00648.x |
|
2005 Conference Publication Population pharmacokinetics: A way forward for optimal dosage prediction in childrenTett, S. E. (2005). Population pharmacokinetics: A way forward for optimal dosage prediction in children. 10th International Congress of Pediatric Laboratory Medicine, Singapore, 3-6 Sept. 2005. Singapore: IAPLM. |
|
2005 Journal Article Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural AustraliaCutts, C. and Tett, S.E. (2005). Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia. Australian Journal of Rural Health, 13 (1), 43-50. doi: 10.1111/j.1440-1854.2004.00644.x |
|
2005 Journal Article Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant periodKiberd, B., Puthenparumpil, J. J., Fraser, A., Tett, S. E. and Lawen, J. (2005). Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplantation Proceedings, 37 (5), 2320-2323. doi: 10.1016/j.transproceed.2005.03.059 |
